atrasentan has been researched along with incretins in 1 studies
| Studies (atrasentan) | Trials (atrasentan) | Recent Studies (post-2010) (atrasentan) | Studies (incretins) | Trials (incretins) | Recent Studies (post-2010) (incretins) |
|---|---|---|---|---|---|
| 358 | 41 | 108 | 2,373 | 249 | 1,914 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heerspink, HJL; Muskiet, MHA; Wheeler, DC | 1 |
1 review(s) available for atrasentan and incretins
| Article | Year |
|---|---|
New pharmacological strategies for protecting kidney function in type 2 diabetes.
Topics: Antihypertensive Agents; Atrasentan; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Endothelin Receptor Antagonists; Humans; Hypoglycemic Agents; Incretins; Mineralocorticoid Receptor Antagonists; Naphthyridines; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2019 |